CELL ADHESION PROTEINS AS BIOMARKER FOR ALZHEIMER'S DISEASE

摘要

The present invention relates to a method for assessing Alzheimer's Disease in vitro comprising measuring in a body fluid sample the level of one or more proteins of the group consisting of Myelin-associated glycoprotein precursor (MAG), Claudin-11, Contactin associated protein 1 precursor, Myelin oligodendrocyte glycoprotein precursor I (MOG), Contactin 1 precursor and Contactin 2 precursor, or a variant thereof, wherein an altered level of one of said proteins is indicative that said individual suffers from Alzheimer's Disease.